Braintree Laboratories clinical trials
Acquired by Sebela Pharmaceuticals, May 1, 2018 · source ↗
The registry lists 49 studies whose lead sponsor is Braintree Laboratories. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.
Before and after it joined Sebela Pharmaceuticals
- First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- 43
- First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- 6
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Braintree Laboratories49 studies
Something wrong with this grouping? Tell us on the Sebela Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 49 of 49. All Sebela Pharmaceuticals studies →
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux DiseaseCompletedNCT05587322Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisCompletedNCT05587309Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux DiseaseCompletedNCT05890001Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety Study of 3 Different Bowel Cleansing PreparationsCompletedNCT01501513Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult SubjectsCompletedNCT03103581Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of BLI4700 Bowel Preparation in Adult SubjectsCompletedNCT03023085Phase 1/2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's DiseaseTerminatedNCT01442363Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic ConstipationCompletedNCT02822508Phase 2/3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT04446299Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT04446312Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of BLI4900 Bowel Preparation in Adult SubjectsCompletedNCT03328507Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open-Label Preference Evaluation of BLI800CompletedNCT04214301Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT03261960Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to ColonoscopyCompletedNCT03404401Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing ColonoscopyCompletedNCT02819323Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing ColonoscopyCompletedNCT02189850Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated AdultsCompletedNCT02481947Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated AdultsCompletedNCT02819297Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study of Chronic Use of BLI400 Laxative in Constipated AdultsCompletedNCT02819310Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent SubjectsCompletedNCT02665728Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic ConstipationCompletedNCT02820714Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne VulgarisCompletedNCT02604680Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing ColonoscopyCompletedNCT02376465Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01815450Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT01786629Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated AdultsCompletedNCT01687985Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00756548Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00756977Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating MedicationsCompletedNCT00153127Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- PolyethyleneGlycol3350 Laxative vs Placebo in Constipated ChildrenCompletedNCT00153114Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic ConstipationCompletedNCT00153140Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated PatientsCompletedNCT00164125Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated ChildrenCompletedNCT00319670Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- HalfLytely Bowel Prep System for ColonoscopyCompletedNCT00164164Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Extended Use of Polyethyleneglycol3350 Laxative in Constipated PatientsCompletedNCT00153153Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.CompletedNCT00164151Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.CompletedNCT00164177Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI1100 for the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01241331Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI801 Laxative in Constipated AdultsCompletedNCT01301781Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry ParametersCompletedNCT00583713Phase 1/2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT00856843Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT00857272Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)CompletedNCT00373334Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated ChildrenCompletedNCT00583609Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated AdultsCompletedNCT00583154Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric PopulationCompletedNCT00425594Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00503607Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00503815Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT00278967Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals